By Dr Mark Enea Montebello

Journal articles

Bhardwaj AK; Mills L; Doyle M; Sahid A; Montebello M; Monds L; Arunogiri S; Haber P; Lorenzetti V; Lubman DI; Malouf P; Harrod ME; Dunlop A; Freeman T; Lintzeris N, 2024, 'A phase III multisite randomised controlled trial to compare the efficacy of cannabidiol to placebo in the treatment of cannabis use disorder: the CBD-CUD study protocol', BMC Psychiatry, 24, http://dx.doi.org/10.1186/s12888-024-05616-3

Heijstee N; Black E; Black E; Demirkol A; Mammen K; Mills L; Deacon R; Ezard N; Montebello M; Reid D; Bruno R; Shakeshaft A; Siefried KJ; Farrell M; Lintzeris N, 2024, 'Sociodemographic and Health Factors of the Alcohol Treatment-seeking Population in New South Wales, Australia', Journal of addiction medicine, 18, pp. 619 - 627, http://dx.doi.org/10.1097/ADM.0000000000001311

Carroll A; Bayes A; Montebello M; Brett J; Arunogiri S; Saunders JB; Loo CK, 2024, 'Drug dependence and prescribing ketamine for treatment-resistant depression in Australia and New Zealand', Australian and New Zealand Journal of Psychiatry, 58, pp. 831 - 838, http://dx.doi.org/10.1177/00048674241242315

Evans S; Lucas BR; Monds LA; Montebello M, 2024, 'Identifying and responding to fetal alcohol spectrum disorder in child and family health: Lessons from an exploratory mixed methods study', Drug and Alcohol Review, 43, pp. 1505 - 1514, http://dx.doi.org/10.1111/dar.13917

Wong G; Venkatesha V; Montebello ME; Masoe A; Cheng K; Cook H; Puszka B; Cheng A, 2024, 'Oral health status and oral health-related quality of life: a cross-sectional study of clients in an Australian opioid treatment program', Australian Journal of Primary Health, 30, http://dx.doi.org/10.1071/PY24021

Broady TR; Valerio H; Alavi M; Wheeler A; Silk D; Martinello M; Conway A; Milat A; Dunlop A; Murray C; Henderson C; Amin J; Read P; Marks P; Degenhardt L; Stevens A; Prain B; Hayllar J; Reid D; Montebello M; Wade A; Christmass M; Cock V; Dore GJ; Treloar C; Grebely J, 2024, 'Factors associated with experiencing stigma, discrimination, and negative health care treatment among people who inject drugs', International Journal of Drug Policy, 128, http://dx.doi.org/10.1016/j.drugpo.2024.104468

Farrell M; Shahbazi J; Chambers M; Byrne M; Gholami J; Zahra E; Grebely J; Lintzeris N; Larance B; Ali R; Nielsen S; Dunlop A; Dore GJ; McDonough M; Montebello M; Weiss R; Rodgers C; Cook J; Degenhardt L, 2024, '96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial', International Journal of Drug Policy, 127, http://dx.doi.org/10.1016/j.drugpo.2024.104390

Morley KC; Kranzler HR; Luquin N; Jamshidi N; Adams C; Montebello M; Tremonti C; Dali G; Logge W; Baillie A; Teesson M; Trent R; Haber PS, 2024, 'Topiramate Versus Naltrexone for Alcohol Use Disorder: A Genotype-Stratified Double-Blind Randomized Controlled Trial', The American journal of psychiatry, 181, pp. 403 - 411, http://dx.doi.org/10.1176/appi.ajp.20230666

Corbett RJ; Blakemore SK; Martin EG; Monds LA; Montebello ME, 2024, 'A call for concern: Frailty in middle-aged adults with alcohol use disorder', Drug and Alcohol Review, 43, pp. 347 - 349, http://dx.doi.org/10.1111/dar.13734

Black E; Bruno R; Mammen K; Mills L; Siefried KJ; Deacon RM; Shakeshaft A; Dunlop AJ; Ezard N; Montebello M; Childs S; Reid D; Holmes J; Lintzeris N, 2023, 'Substance use, socio-demographic characteristics, and self-rated health of people seeking alcohol and other drug treatment in New South Wales: baseline findings from a cohort study', Medical Journal of Australia, 219, pp. 218 - 226, http://dx.doi.org/10.5694/mja2.52039

Grover C; Monds L; Montebello M, 2023, 'A survey of Australian psychiatrists’ and psychiatry trainees’ knowledge of and attitudes towards psychedelics in the treatment of psychiatric disorders', Australasian Psychiatry, 31, pp. 329 - 335, http://dx.doi.org/10.1177/10398562231155125

Black E; Mammen K; Deacon RM; Ezard N; Mills L; Dunlop AJ; Montebello M; Reid D; Childs S; Bruno R; Shakeshaft A; Siefried KJ; Farrell M; Holmes J; Lintzeris N, 2023, 'Health and social characteristics of clients reporting amphetamine type substance use at entry to public alcohol and other drug services in New South Wales, Australia, 2016–2019', Drug and Alcohol Review, 42, pp. 389 - 400, http://dx.doi.org/10.1111/dar.13588

Valerio H; Conway A; Alavi M; Treloar C; Silk D; Murray C; Henderson C; Amin J; Read P; Degenhardt L; Christmass M; Montebello M; Dore GJ; Grebely J, 2022, 'Awareness of hepatitis C virus infection status among people who inject drugs in a setting of universal direct-acting antiviral therapy: The ETHOS Engage study', International Journal of Drug Policy, 110, http://dx.doi.org/10.1016/j.drugpo.2022.103876

Mills L; Dunlop A; Montebello M; Copeland J; Bruno R; Jefferies M; Mcgregor I; Lintzeris N, 2022, 'Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder', Substance Abuse: Treatment, Prevention, and Policy, 17, http://dx.doi.org/10.1186/s13011-022-00493-z

Carson JM; Hajarizadeh B; Hanson J; O'Beirne J; Iser D; Read P; Balcomb A; Davies J; Doyle JS; Yee J; Martinello M; Marks P; Matthews GV; Dore GJ; Post J; Batey R; Smart J; Dawson O; Hill S; Douglas M; Montebello M; Collie P; Hallinan R; Snelgar G; Baker D; Galhenage S; Soo TM; Bopage R; Faros J; Cooper L; Nelson R; Shaw D; Wilson M; Pratt W; Hinton S; Wade A; Van Gessel H; Davidson L; Dibdin M; Lucas M; Ahmad R; Smith D; Tan K; Roder C; Harney B; Holdaway S; Walsh J; Fox P; Mousavi R; Lam W; Dahal RP; Habel P; Gilliver R; Silins E; Ackerman J; Deacon R; Hall E; Everson A; Stewart J; Milner M; Ferguson C; Tate-Baker J; Bradshaw J; Duncan G; Baluran G; Watson B; Hey C; Hickey R; Orme C; Miczkova S, 2022, 'Retreatment for hepatitis C virus direct-acting antiviral therapy virological failure in primary and tertiary settings: The REACH-C cohort', Journal of Viral Hepatitis, 29, pp. 661 - 676, http://dx.doi.org/10.1111/jvh.13705

Conway A; Valerio H; Alavi M; Silk D; Treloar C; Hajarizadeh B; Marshall AD; Martinello M; Milat A; Dunlop A; Murray C; Prain B; Henderson C; Amin J; Read P; Marks P; Degenhardt L; Hayllar J; Reid D; Gorton C; Lam T; Christmass M; Wade A; Montebello M; Dore GJ; Grebely J, 2022, 'A Testing Campaign Intervention Consisting of Peer-Facilitated Engagement, Point-of-Care HCV RNA Testing, and Linkage to Nursing Support to Enhance Hepatitis C Treatment Uptake among People Who Inject Drugs: The ETHOS Engage Study', Viruses, 14, http://dx.doi.org/10.3390/v14071555

Vuong T; Gillies M; Larney S; Montebello M; Ritter A, 2022, 'The association between involuntary alcohol treatment and subsequent emergency department visits and hospitalizations: a Bayesian analysis of treated patients and matched controls', Addiction, 117, pp. 1589 - 1597, http://dx.doi.org/10.1111/add.15755

Montebello M; Jefferies M; Mills L; Bruno R; Copeland J; McGregor I; Rivas C; Jackson MA; Silsbury C; Dunlop A; Lintzeris N, 2022, 'Mood, sleep and pain comorbidity outcomes in cannabis dependent patients: Findings from a nabiximols versus placebo randomised controlled trial', Drug and Alcohol Dependence, 234, http://dx.doi.org/10.1016/j.drugalcdep.2022.109388

Yee J; Carson JM; Hajarizadeh B; Hanson J; O’Beirne J; Iser D; Read P; Balcomb A; Doyle JS; Davies J; Martinello M; Marks P; Dore GJ; Matthews GV; Hanson J; Marks P; Byrne M; Post J; Batey R; Smart J; Dawson O; Hill S; Douglas M; Montebello M; Collie P; Hallinan R; Snelgar G; Baker D; Galhenage S; Soo TM; Bopage R; Faros J; Cooper L; Nelson R; Shaw D; Davies J; Wilson M; Pratt W; Hinton S; Wade A; Van Gessel H; Davidson L; Dibdin M; Lucas M; Ahmad R; Smith D; Tan K; Roder C; Harney B; Holdaway S; Walsh J; Fox P; Mousavi R; Lam W; Dahal RP; Habel P; Gilliver R; Silins E; Ackerman J; Deacon R; Hall E; Everson A; Milner M; Ferguson C; Tate-Baker J; Bradshaw J; Duncan G; Baluran G; Watson B; Hey C; Hickey R; Orme C; Miczkova S, 2022, 'High Effectiveness of Broad Access Direct-Acting Antiviral Therapy for Hepatitis C in an Australian Real-World Cohort: The REACH-C Study', Hepatology Communications, 6, pp. 496 - 512, http://dx.doi.org/10.1002/hep4.1826

Farrell M; Shahbazi J; Byrne M; Grebely J; Lintzeris N; Chambers M; Larance B; Ali R; Nielsen S; Dunlop A; Dore GJ; McDonough M; Montebello M; Nicholas T; Weiss R; Rodgers C; Cook J; Degenhardt L, 2022, 'Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence', International Journal of Drug Policy, 100, http://dx.doi.org/10.1016/j.drugpo.2021.103492

Valerio H; Alavi M; Conway A; Silk D; Treloar C; Martinello M; Milat A; Dunlop A; Murray C; Henderson C; Amin J; Read P; Marks P; Degenhardt L; Stevens A; Prain B; Hayllar J; Reid D; Montebello M; Wade A; Christmass M; Cock V; Dore GJ; Grebely J; ETHOS Engage Study Group , 2022, 'Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: The ETHOS Engage study.', Int J Drug Policy, 105, pp. 103706, http://dx.doi.org/10.1016/j.drugpo.2022.103706

Kwon I; Blazey A; Montebello M, 2021, 'The successful treatment of Kamini dependence with depot buprenorphine (Buvidal) – a case report', Australasian Psychiatry, 29, pp. 707, http://dx.doi.org/10.1177/10398562211014214

Jackson MA; Brown AL; Johnston J; Clancy R; McGregor I; Bruno R; Lintzeris N; Montebello M; Luksza J; Bowman J; Phung N; Allsop D; Dunlop AJ, 2021, 'The use and effects of synthetic cannabinoid receptor agonists by New South Wales cannabis treatment clients', Journal of Cannabis Research, 3, http://dx.doi.org/10.1186/s42238-021-00091-z

Conway A; Valerio H; Peacock A; Degenhardt L; Hayllar J; Harrod ME; Henderson C; Read P; Gilliver R; Christmass M; Dunlop A; Montebello M; Whitton G; Reid D; Lam T; Alavi M; Silk D; Marshall AD; Treloar C; Dore GJ; Grebely J, 2021, 'Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS Engage study', International Journal of Drug Policy, 96, http://dx.doi.org/10.1016/j.drugpo.2021.103421

Kwon I; Montebello M; Bittoun R, 2021, 'Tobacco dependence management in a smoke-free inpatient drug and alcohol unit', Australasian Psychiatry, 29, pp. 14 - 21, http://dx.doi.org/10.1177/1039856220975287

Lintzeris N; Mills L; Dunlop A; Copeland J; Mcgregor I; Bruno R; Kirby A; Montebello M; Hall M; Jefferies M; Kevin R; Bhardwaj A, 2020, 'Cannabis use in patients 3 months after ceasing nabiximols for the treatment of cannabis dependence: Results from a placebo-controlled randomised trial', Drug and Alcohol Dependence, 215, http://dx.doi.org/10.1016/j.drugalcdep.2020.108220

Grebely J; Read P; Cunningham EB; Weltman M; Matthews GV; Dunlop A; Montebello M; Martinello M; Gilliver R; Marks P; Applegate TL; Dore GJ, 2020, 'Elbasvir and grazoprevir for hepatitis C virus genotype 1 infection in people with recent injecting drug use (DARLO-C): An open-label, single-arm, phase 4, multicentre trial', Health Science Reports, 3, http://dx.doi.org/10.1002/hsr2.151

Mills L; Lintzeris N; Bruno R; Montebello M; Dunlop A; Deacon RM; Copeland J; Jefferies M; Rivas C; Mammen K, 2020, 'Validation of the Australian Treatment Outcomes Profile for use in clients with cannabis dependence', Drug and Alcohol Review, 39, pp. 356 - 364, http://dx.doi.org/10.1111/dar.13050

Lintzeris N; Bhardwaj A; Mills L; Dunlop A; Copeland J; McGregor I; Bruno R; Gugusheff J; Phung N; Montebello M; Chan T; Kirby A; Hall M; Jefferies M; Luksza J; Shanahan M; Kevin R; Allsop D, 2019, 'Nabiximols for the Treatment of Cannabis Dependence: A Randomized Clinical Trial', JAMA Internal Medicine, 179, pp. 1242 - 1253, http://dx.doi.org/10.1001/jamainternmed.2019.1993

Jones NR; Shanahan M; Dobbins T; Degenhardt L; Montebello M; Gisev N; Larney S, 2019, 'Reductions in emergency department presentations associated with opioid agonist treatment vary by geographic location: A retrospective study in New South Wales, Australia', Drug and Alcohol Review, 38, pp. 690 - 698, http://dx.doi.org/10.1111/dar.12976

Jacobs NI; Montebello M; Monds LA; Lintzeris N, 2019, 'Survey of Australian psychiatrists’ and psychiatry trainees’ knowledge about and attitudes towards medicinal cannabinoids', Australasian Psychiatry, 27, pp. 80 - 85, http://dx.doi.org/10.1177/1039856218803675

Bhardwaj AK; Allsop DJ; Copeland J; McGregor IS; Dunlop A; Shanahan M; Bruno R; Phung N; Montebello M; Sadler C; Gugusheff J; Jackson M; Luksza J; Lintzeris N; Hall M; Hazelwood S; Winmill A; Chan T; Dojcinovic R; Jago B; McKendrick L; Rivas C; Schwanz R; Yang A; Zavareh Z; Barbaro A; Black K; Ho T; Jefferies M; Jule JC; Nagubandi S; Shahidi M; Lisa Snell CS; Wijanto M, 2018, 'Randomised Controlled Trial (RCT) of cannabinoid replacement therapy (Nabiximols) for the management of treatment-resistant cannabis dependent patients: A study protocol', BMC Psychiatry, 18, http://dx.doi.org/10.1186/s12888-018-1682-2

Lintzeris N; Monds LA; Rivas C; Leung S; Dunlop A; Newcombe D; Walters C; Galea S; White N; Montebello M; Demirkol A; Swanson N; Ali R, 2018, 'Transferring Patients from Methadone to Buprenorphine: The Feasibility and Evaluation of Practice Guidelines', Journal of Addiction Medicine, 12, pp. 234 - 240, http://dx.doi.org/10.1097/ADM.0000000000000396

Allsop DJ; Rooney K; Arnold JC; Bhardwaj AK; Bruno R; Bartlett DJ; Montebello M; Arkell T; Richards E; Gugusheff J; Rooke S; Kerley W; Murnion B; Haber P; McGregor IS; Lintzeris N, 2017, 'Randomised controlled trial (RCT) of daily aerobic exercise for inpatient cannabis withdrawal: A study protocol', Mental Health and Physical Activity, 13, pp. 57 - 67, http://dx.doi.org/10.1016/j.mhpa.2017.06.002

Montebello ME; Brett B, 2015, 'Misuse and associated harms of quetiapine and other atypical antipsychotics', Current Topics in Behavioral Neurosciences, pp. 1 - 15, http://dx.doi.org/10.1007/7854_2015_424

Allsop DJ; Copeland J; Lintzeris N; Dunlop AJ; Montebello M; Sadler C; Rivas GR; Holland RM; Muhleisen P; Norberg MM; Booth J; McGregor IS, 2014, 'Nabiximols as an agonist replacement therapy during cannabis withdrawal:A randomized clinical trial', JAMA Psychiatry, 71, pp. 281 - 291, http://dx.doi.org/10.1001/jamapsychiatry.2013.3947

Bruno R; Allsop DJ; Copeland J; Lintzeris N; McGregor I; Norberg M; Dunlop A; Montebello M; Sadler C; Holland R; Rivas G, 2014, 'The impact of Sativex® on cognitive function during treatment for cannabis withdrawal', Drug and Alcohol Dependence, 140, pp. e22 - e22, http://dx.doi.org/10.1016/j.drugalcdep.2014.02.082

Allsop DJ; Copeland J; Lintzeris N; Dunlop AJ; Montebello M; Sadler C; Rivas GR; Holland RM; Muhleisen P; Norberg MM; Booth J; McGregor I, 2013, 'A RANDOMISED CONTROLLED TRIAL OF SATIVEX (R) AS AN AGONIST REPLACEMENT THERAPY DURING CANNABIS WITHDRAWAL', DRUG AND ALCOHOL REVIEW, 32, pp. 23 - 24, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000326649400077&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Bruno R; Allsop DJ; Copeland J; McGregor L; Norberg MM; Dunlop AJ; Montebello M; Sadler C; Holland RM; Rivas G; Muhleisen P; Booth J; Lintzeris N, 2013, 'THE IMPACT OF SATIVEX (R) ON COGNITIVE FUNCTION DURING TREATMENT FOR CANNABIS WITHDRAWAL', DRUG AND ALCOHOL REVIEW, 32, pp. 27 - 27, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000326649400088&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Wong A; Montebello ME; Norberg MM; Rooney K; Lintzeris N; Bruno R; Booth J; Arnold JC; Mcgregor I, 2013, 'Exercise increases plasma THC concentrations in regular cannabis users', Drug and Alcohol Dependence, http://dx.doi.org/10.1016/j.drugalcdep.2013.07.031

Montebello ME; Mendelsohn C, 2013, 'Smokers with mental illness: breaking down the myths', Medicine Today, 14, pp. 53 - 56, http://www.medicinetoday.com.au/2013/august/article/smokers-mental-illness-breaking-down-myths

Montebello M; Wong A; Norberg M; Lintzeris N; Mcgregor I; Arnold J, 2012, 'REINTOXICATION: CAN DIET AND EXERCISE RAISE BLOOD PLASMA Delta(9)-THC LEVELS IN LONG-TERM HEAVY CANNABIS USERS?', DRUG AND ALCOHOL REVIEW, 31, pp. 57 - 57, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000311236700176&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Frewen AR; Baillie AJ; Montebello ME, 2009, 'Are cannabis users who participate in a randomized clinical trial different from other treatment seekers?', Journal of Substance Abuse Treatment, 36, pp. 339 - 344, http://dx.doi.org/10.1016/j.jsat.2008.07.004

Cruickshank C; Montebello ME; Dyer K; Quigley A; Blaszczyk J; Tomkins S; Shand D, 2008, 'A placebo-controlled trial of mirtazapine for the management of methamphetamine withdrawal', Drug and Alcohol Review, 27, pp. 326 - 333

Back to profile page